Matches in UGent Biblio for { <https://biblio.ugent.be/publication/383099#aggregation> ?p ?o. }
Showing items 1 to 36 of
36
with 100 items per page.
- aggregation classification "A1".
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2007".
- aggregation format "application/pdf".
- aggregation hasFormat 383099.bibtex.
- aggregation hasFormat 383099.csv.
- aggregation hasFormat 383099.dc.
- aggregation hasFormat 383099.didl.
- aggregation hasFormat 383099.doc.
- aggregation hasFormat 383099.json.
- aggregation hasFormat 383099.mets.
- aggregation hasFormat 383099.mods.
- aggregation hasFormat 383099.rdf.
- aggregation hasFormat 383099.ris.
- aggregation hasFormat 383099.txt.
- aggregation hasFormat 383099.xls.
- aggregation hasFormat 383099.yaml.
- aggregation isPartOf urn:issn:1356-1294.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Medical evidence and health policy: a marriage of convenience?: the case of proton pump inhibitors".
- aggregation abstract "Rationale In Belgium, several policies regulating reimbursement of acid suppressant drugs and evidence-based recommendations for clinical practice were issued in a short period of time, creating a unique opportunity to observe their effect on prescribing. Aims and objectives To describe the evolution of prescriptions for acid suppressants and explore the interaction of policies and practice recommendations with prescribing patterns. Method Monthly claims-based data for proton pump inhibitors (PPIs) and H-2-antihistamines by general practitioners, internists and "astroenterologists were obtained from the Belgian national health insurance database (1997-2005). The evolution of reimbursed defined daily doses and expenses after introduction of reimbursement regulations and dissemination of practice recommendations was explored. Results Recommendations had no impact on prescribing. All changes can be related to concomitant policies. Lifting reimbursement restrictions for cheaper products did not control growth or save costs in the Iona term. Only restricting reimbursement of all PPIs managed to curb the growth. We observed an unintended increase of non-omeprazole PPIs by gastroenterologists. Conclusions Reimbursement policies influence prescribing, but their effect can be unintended. A dialogue between policymakers and guideline developers, and evidence-based policies that are linked to clinical guidelines, could be an effective way to pursue both cost-containment and quality of care.".
- aggregation authorList BK685304.
- aggregation endPage "680".
- aggregation issue "4".
- aggregation startPage "674".
- aggregation volume "13".
- aggregation aggregates 2081937.
- aggregation isDescribedBy 383099.
- aggregation similarTo j.1365-2753.2007.00829.x.
- aggregation similarTo LU-383099.